Production of interleukin-4, interferon (IFN)-γ and IFN-α in human immunodeficiency virus-1 infection: An imbalance of type 1 and type 2 cytokines may reduce the synthesis of IFN-α

Scandinavian Journal of Immunology

Volumn 48, Issue 4, 1998, Pages 436-442

  Hober, D ^a   Benyoucef, S ^a   Chehadeh, W ^a   Chieux, V ^a   De La Tribonniere, X ^b   Mouton, Y ^b   Bocket, L ^a   Wattre, P ^a  

^a CHU Rouen BG   (France)

^b CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; SENDAI VIRUS; VIRUS INFECTION;

ADULT; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-4; T-LYMPHOCYTES;

EID: 0031682062     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00417.x     Document Type: Article

References (45)

1. Kirchner H. The interferon system as an integral part of the defense system against infections. Antivir Res 1986;6:1-17.
2. Zawatzky R, Ifenhaus JH, Marcucci F, Kirchner H. Experimental infection of inbred mice with Herpes Simplex Virus I. I. Investigation of humoral and cellular immunity and of interferon induction. J Gen Virol 1983;53:31-8.
3. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 1990;54:200-19.
4. Pitha PM. Multiple effects of interferon on HIV-1 replication. J Inter Res 1991;11:313-18.
5. Samuel CS. Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11.
6. Francis ML, Meltzer MS, Gendelman HE. Interferons in the persistence, pathogenesis, and treatment of HIV infection. Aids Res Hum Retrovirus 1992;8:199-207.
7. Rappocciolo G, Toso JF, Torpey III DJ, Gupta P, Rinaldo CR Jr Association of a interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus J Clin Microbiol 1989;27:41-8.
8. Gendelman HE, Baca LM, Turpin JA, Kalter DC, Hansen B, Orenstein JM, Dieffenbach C, Friedman RM, Meltzer MS. Regulation of HIV replication in infected monocytes by IFN-α: Mechanisms for viral restriction. J Immunol 1990;145:2669-76.
9. Brinchmann JE, Gaudernack G, Vartdal F. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN-α2 and by a soluble factor secreted by activated CD8+ T cells but not by rIFN-β, rIFN-γ, or rTNF-α. J Acq Immun Defic Synd Hum Res 1991;4:480-8.
10. Hansen BD, Nara PL, Maheshwari RK, Sidhu GS, Bernbaum JG, Hoekzema D, Meltzer MS, Gendelman HE. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type-1 infected T cells is associated with defective assembly of envelope gp 120. J Virol 1992;66:7543-8.
11. Shirazi Y, Pitha PM. α-interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol 1992;66: 1321-8.
12. Lopez C, Fitzgerald PA, Siegal FP. Severe acquired immune deficiency syndrome in male homosexuals: Diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections. J Infect Dis 1983;148:962-6.
13. Rossol S, Voth R, Laubenstein HPM, Müller WEG, Schröder HC, Meyer Zum Buschenfelde KH, Hess G. Interferon production in patients infected with HIV-1. J Infect Dis 1989;159:815-21.
14. Voth R, Rossol S, Klein K, Hess G, Schutt KH, Schröder HC, Meyer Zum Buschenfelde KHM, Müller WEG. Differential gene expression of IFN-α and tumor necrosis factor-α in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol 1990;144:970-5.
15. Howell DM, Feldman SB, Kloser P, Fitzgerald-Bocarsly P. Decreased frequency of functional natural interferon-producing cells in peripheral blood of patients with the acquired immune deficiency syndrome. Clin Immunol Immunopathol 1994;71:223-30.
16. Piasecki E, Ledwon TK, Inglot AD, Knysz B, Simon K, Inglot M, Gladysz A. Interferon and tumor necrosis factor responses of HIV+ patients as markers for monitoring of the AIDS progression. Arch Immunol Ther Experiment 1994;42:439-45.
17. Feldman BS, Milone MC, Klosser P, Fitzgerald-Bocarsly P. Functional deficiencies in two distinct Interferon α-inducing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients. J Leuk Biol 1995;57:214-20.
18. Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dveksler G, Meltzer MS, Dieffenbach C. A selective defect of interferon a production in human immunodeficiency virus-infected monocytes. J Exp Med 1990;172:1433-42.
19. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. Apmis 1995;103:161-79.
20. Belardelli F, Gresser I. The neglected role of type 1 interferon in T-cell response: Implications for its clinical use. Immunol Today 1996;17:369-72.
21. Gobi AE, Funa K, Aim GV. Different induction patterns of mRNA for IFN-α and -β in human mononuclear leukocytes after in vitro challenge with Herpes Simplex Virus-infected fibroblasts and Sendai virus. J Immunol 1988;140:3605-9.
22. Rosztoczy I, Content J. The effects of various cytokines of interleukin-6 and interferon-α synthesis in human peripheral blood mononuclear cells. J Interferon Res 1990;10:637-45.
23. Cederblad B, Aim GV. Interferons and the colony stimulating factors IL-3 and GM-CSF enhance the IFN-α response in human blood leucocytes induced by Herpes Simplex Virus. Scand J Immunol 1991;34:549-55.
24. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. Aids 1994;8:757-62.
25. Clerici M, Ballota C, Salvaggio A et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2 / interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996;88:574-9.
26. Clerici M, Ballota C, Meroni L et al. type 1 cytokine production and low prevalence of viral isolation correlate with long-term non-progression in HIV infection. Aids Res Hum Retrovirus 1996;12:1053-61.
27. Center for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993 1-19.
28. Benyoucef S, Hoher D, De Groote D, La Trihonniere X, Vilain V, Lion G, Bouzidi A, Wattré P. An interferon-γ (IFN-γ) based whole blood assay to detect T cell response to antigens in HIV-1 infected patients. Pathol Biol 1997;45:400-3.
29. Hober D, Lucas B, Wattré P, Capron A, Haque A. TNF-α production by U937 promonocytes is enhanced by factors released from HIV-infected T lymphocytes: TNF-α is one of the mediators causing HIV-infected T4 cells lysis. Clin Immunol Immunopathol 1992;62:168-75.
30. Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA. Generation of a novel copy-back non-defective interfering virus. EMBO J 1995;14:6087-94.
31. Lebon P, Commoy-Chevalier MJ, Robert-Galliot B, Morin A, Chany C. Production interfron humain de type 1 par des lymphocytes au contact de cellules infectes par le virus herpes et fixes par le glutaraldehhyde. C R Acad Sci Ser D 1980;290:37-40.
32. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood I. comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
33. Uno K, Nakano K, Maruo N et al. Determination of interferon-α-producing capacity in whole blood cultures from patients with various diseases and from healthy persons. J Interferon Cytokine Res 1996;16:911-8.
34. Leroux M, Schindler L, Braun R, Doerr HW, Geisen HP, Kirchner H. A whole blood lymphoproliferation assay for measuring cellular immunity against herpes viruses. J Immunol Meth 1985;79: 251-62.
35. Fiavey NP, Frankenberg S. Appraisal of the total blood lymphocyte proliferation assay as a diagnostic tool in screening for tuberculosis. J Med Microbiol 1992;37:283-5.
36. Weir RE, Morgan AR, Britton WJ, Butlin CR, Dockrell HM. Development of a whole blood assay to measure T-cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J Immunol Meth 1994;176:93-101.
37. Saksela E, Virtanen I, Hovi T, Secher DS, Cantell K. Monocyte is the main producer of human alpha interferons following Sendai virus induction. Prog Med Virol 1984;30:78-86.
38. Sandberg K, Matsson P, Alm GV. A distinct population of non-phagocytic and low level CD4+ null lymphocytes produce IFN-α after stimulation by Herpes Simplex Virus-infected cells. J Immunol 1990;145:1015-20.
39. Feldman M, Fitzgerald-Bocarsly P. Sequential enrichment and immunocytochemical visualization of human interferon-α producing cells. J Interferon Res 1999;10:435-46.
40. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993;12:2663-70.
41. Lauener RP, Goyert SM, Geha RS, Vercelli D. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol 1990;20:2375-81.
42. Gobi AE, Aim GV. Interleukin-4 down-regulates Sendai virus-induced production of interferon-α and -β in human peripheral blood monocytes in vitro. Scand J Immunol 1992;35:167-75.
43. De Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, De Vries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 andmodulation by IFN-g or IL-10. J Immunol 1993;151:6370-81.
44. Nickolaus P, Zawatzky R. Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages. J Virol 1994;68:6763-6.
45. Tyring SK, Cauda R, Tumharello M, Ortona L, Kennedy RC, Chanh TC, Kanda P. Synthetic peptides corresponding to sequences in HIV envelope gp 41 and gp 120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-α, interferon-γ and interleukin-2. Viral Immunol 1991;4:33-42.